Cafepharma Today

May 20 2025 - FDA outlines stricter Covid vaccine booster approval standards for healthy people
FDA outlines stricter Covid vaccine booster approval standards for healthy people
AHA warns tariffs could worsen drug shortages, pushes for long-term reform
Surveyed via text, HCPs say they want more interactions with pharma
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Morning Movers in Biotech: Medicines Co., Omeros Corporation, Opko Health, Inc. and VIVUS, Inc.
Motley Fool
Thursday, April 3, 2014 - 9:21am
tags:
Medicines Company, Omeros, OPKO Health, Vivus, OMS721, Qsymia, Fibrocaps
Apricus Biosciences granted national phase approval for Vitaros in Luxembourg
The Fly on the Wall
Thursday, April 3, 2014 - 9:19am
tags:
Apricus Biosciences, erectile dysfunciton, Vitaros, Luxembourg
BioDelivery Sciences Announces First Patient Enrollment in Phase 3 Clinical Study of Clonidine
Yahoo/Benzinga
Thursday, April 3, 2014 - 9:17am
tags:
clonidine, BioDelivery Sciences, diabetic neuropathy
Biotech: The One Sector Where Crash Helmets Are Advised
Seeking Alpha
Thursday, April 3, 2014 - 9:02am
tags:
biotech, IPOs
FDA bans imports from Canadian drugmaker Apotex's India plant
Yahoo/Reuters
Thursday, April 3, 2014 - 9:01am
tags:
FDA, India, Canada, Apotex, drug manufacturing
How MannKind Shows Depth Of The Diabetes Market
Seeking Alpha
Thursday, April 3, 2014 - 8:59am
tags:
MannKind, diabetes, Afrezza
Northwest Bio Warns FDA May Throw Out Phase III Brain Cancer Study
TheStreet.com
Thursday, April 3, 2014 - 8:58am
tags:
FDA, Northwest Biotherapeutics, glioblastoma multiforme, DCVax
GlaxoSmithKline yanks Paxil batches after FDA warning letter
Fierce Pharma
Wednesday, April 2, 2014 - 10:03pm
tags:
FDA, Paxil, warnings, GSK
Gilead says Japanese hepatitis C trial meets goal
Yahoo/Reuters
Wednesday, April 2, 2014 - 10:01pm
tags:
Gilead Sciences, Japan, hepatitis C, sofosbuvir
Amarin triples size of Vascepa sales force with Kowa promo deal
Fierce Pharma
Wednesday, April 2, 2014 - 9:53pm
tags:
Kowa, hirings, Amarin, drug reps, Vascepa
After Bristol Myers' Bydureon Success, The Next Step Is Sustained Release Insulin
Seeking Alpha
Wednesday, April 2, 2014 - 9:52pm
tags:
Bydureon, insulin, Bristol-Myers Squibb, diabetes
The Medicines Co. Falls on Angiomax Woes
Yahoo/Zacks.com
Wednesday, April 2, 2014 - 9:51pm
tags:
Angiomax, The Medicines Company, patents
IPO Preview: Scynexis
Seeking Alpha
Wednesday, April 2, 2014 - 9:46pm
tags:
IPOs, Scynexis, anti-infectives
Sanofi eyes more acquisitions, sees growth in Africa
Yahoo/Reuters
Wednesday, April 2, 2014 - 9:44pm
tags:
Sanofi, Africa, M&A, Chris Viehbacher
IPO Preview: Corium International
Seeking Alpha
Wednesday, April 2, 2014 - 9:42pm
tags:
IPOs, Corium International, transdermal drug delivery
Gilead Sciences: What If Sovaldi Sales Peak Quickly, Fall Fast?
Barron's
Wednesday, April 2, 2014 - 9:41pm
tags:
Sovaldi, hepatitis C, Gilead Sciences
Myriad shares soar after Medicare reimbursements get a 37% boost
Marketwatch
Wednesday, April 2, 2014 - 9:40pm
tags:
Medicare, Myriad Genetics
FDA defends generic drug label proposal at U.S. House hearing
Yahoo/Reuters
Wednesday, April 2, 2014 - 7:48am
tags:
FDA, generics, labeling
Can MannKind Shares Double Again on FDA Approval?
24/7 Wall St
Wednesday, April 2, 2014 - 7:46am
tags:
FDA, Afrezza, diabetes, MannKind
A Second Lawsuit Tests the BPCIA Biosimilars “Patent Dance” Waters
FDA Law Blog
Wednesday, April 2, 2014 - 7:45am
tags:
patents, biosimilars, Celltrion, Janssen Biotech, Remicade

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.